The research advances on treatment of secondary hypersplenism in the patients with cirrhosis and portal hypertension
10.3760/cma.j.issn.1007-8118.2019.12.018
- VernacularTitle: 肝硬化门静脉高压症患者继发脾功能亢进的治疗研究进展
- Author:
Guangpeng ZHOU
1
;
Zhijun ZHU
;
Lin WEI
Author Information
1. Liver Transplantation Center, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China; Clinical Center for Pediatric Liver Transplantation, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China; National Clinical Research Center for Digestive Diseases, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China
- Publication Type:Review
- Keywords:
Liver cirrhosis;
Hypertension, portal;
Hypersplenism;
Combined therapy;
Occurrence mechanism
- From:
Chinese Journal of Hepatobiliary Surgery
2019;25(12):952-956
- CountryChina
- Language:Chinese
-
Abstract:
Hypersplenism is a common and serious complication in patients with cirrhosis and portal hypertension. Currently, the therapeutic options for severe hypersplenism mainly include total splenectomy, partial splenic embolization, local thermal ablation, splenic artery ligation, surgical shunt, and partial splenectomy. This article discussed the current progress in the relative mechanisms and invasive treatment of severe secondary hypersplenism in the patients with cirrhosis and portal hypertension.
